Complimentary access Industry-leading global pharmaceutical pricing data

For firms seeking to analyze the impact of President Trump’s executive order on international reference pricing

On 24 July, President Trump signed an executive order proposing a reform that would ensure the Medicare program and US seniors pay no more for the most-costly Medicare Part B drugs than any economically comparable OECD country. The order takes effect in 30 days unless Congress acts. Until then, GlobalData is offering unique access to its pharmaceutical pricing database to allow domestically focused and global firms the opportunity to examine the potential impact of this watershed order.

To access the POLI trial, please provide your details and our team will contact you shortly upon submission.

Please complete the form and one of our team will be in touch with you shortly